Autoimmunity ReviewsVolume 19, Issue 7, July 2020, 102565Imatinib might constitute a treatment option for lung involvement in COVID-19Author links open overlay panelDavid Bernal-Bello a, Beatriz Jaenes-Barrios b, Alejandro Morales-Ortega a, José Manuel Ruiz-Giardin a, Virginia García-Bermúdez a, Begoña Frutos-Pérez a, Ana Isabel Farfán-Sedano a, Cristina de Ancos-Aracil a, Fernando Bermejo c, Mario García-Gil d, Antonio Zapatero-Gaviria a, Juan Víctor San Martín-López aShow moreShareCitehttps://doi.org/10.1016/j.autrev.2020.102565Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract© 2020 Elsevier B.V. All rights reserved.